Literature DB >> 20538729

Large-scale benchmark of Endeavour using MetaCore maps.

Sven Schuierer1, Léon-Charles Tranchevent, Uwe Dengler, Yves Moreau.   

Abstract

SUMMARY: Endeavour is a tool that detects the most promising genes within large lists of candidates with respect to a biological process of interest and by combining several genomic data sources. We have benchmarked Endeavour using 450 pathway maps and 826 disease marker sets from MetaCore of GeneGo, Inc. containing a total of 9911 and 12 432 genes, respectively. We obtained an area under the receiver operating characteristic curves of 0.97 for pathway and of 0.91 for disease gene sets. These results indicate that Endeavour can be used to efficiently prioritize candidate genes for pathways and diseases. AVAILABILITY: Endeavour is available at http://www.esat.kuleuven.be/endeavour

Mesh:

Substances:

Year:  2010        PMID: 20538729     DOI: 10.1093/bioinformatics/btq307

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  18 in total

Review 1.  Computational tools for prioritizing candidate genes: boosting disease gene discovery.

Authors:  Yves Moreau; Léon-Charles Tranchevent
Journal:  Nat Rev Genet       Date:  2012-07-03       Impact factor: 53.242

Review 2.  Whole-genome and whole-exome sequencing in neurological diseases.

Authors:  Jia-Nee Foo; Jian-Jun Liu; Eng-King Tan
Journal:  Nat Rev Neurol       Date:  2012-07-31       Impact factor: 42.937

Review 3.  Role of miRNAs in hypoxia-related disorders.

Authors:  A Gupta; R Sugadev; Y K Sharma; Y Yahmad; P Khurana
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

4.  Exome-sequencing confirms DNAJC5 mutations as cause of adult neuronal ceroid-lipofuscinosis.

Authors:  Bruno A Benitez; David Alvarado; Yefei Cai; Kevin Mayo; Sumitra Chakraverty; Joanne Norton; John C Morris; Mark S Sands; Alison Goate; Carlos Cruchaga
Journal:  PLoS One       Date:  2011-11-04       Impact factor: 3.240

5.  Concordance of changes in metabolic pathways based on plasma metabolomics and skeletal muscle transcriptomics in type 1 diabetes.

Authors:  Tumpa Dutta; High Seng Chai; Lawrence E Ward; Aditya Ghosh; Xuan-Mai T Persson; G Charles Ford; Yogish C Kudva; Zhifu Sun; Yan W Asmann; Jean-Pierre A Kocher; K Sreekumaran Nair
Journal:  Diabetes       Date:  2012-03-13       Impact factor: 9.461

6.  Prognostic and Immunological Role of mRNA ac4C Regulator NAT10 in Pan-Cancer: New Territory for Cancer Research?

Authors:  Chuanxi Yang; Tingting Wu; Jing Zhang; Jinhui Liu; Kun Zhao; Wei Sun; Xin Zhou; Xiangqing Kong; Jing Shi
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

7.  Comprehensive Analysis of the Transcriptome-Wide m6A Methylome in Pterygium by MeRIP Sequencing.

Authors:  Yaping Jiang; Xin Zhang; Xiaoyan Zhang; Kun Zhao; Jing Zhang; Chuanxi Yang; Yihui Chen
Journal:  Front Cell Dev Biol       Date:  2021-06-25

8.  Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.

Authors:  Eugenia Trushina; Tumpa Dutta; Xuan-Mai T Persson; Michelle M Mielke; Ronald C Petersen
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

9.  The Phytochemical Shikonin Stimulates Epithelial-Mesenchymal Transition (EMT) in Skin Wound Healing.

Authors:  Shu-Yi Yin; An-Ping Peng; Li-Ting Huang; Ya-Ting Wang; Chun-Wen Lan; Ning-Sun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-03       Impact factor: 2.629

10.  Navigating traditional chinese medicine network pharmacology and computational tools.

Authors:  Ming Yang; Jia-Lei Chen; Li-Wen Xu; Guang Ji
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-31       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.